January 25, 2019

Eton Pharmaceuticals Announces Licensing of Oral Liquid Product Candidate ET-104

Eton Pharmaceuticals (NASDAQ:ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products, today announced that it has...
December 3, 2018

4 Life Science IPOs in November

November brought four life science IPOs on the NYSE and NASDAQ, giving investors new opportunities to enter the market.